Serum tumor makers, such as neuron‐specific enolase (NSE), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125) and CA153, are frequently used in practice for LC diagnosis (6). This evidence concerns the gene ENO2 and laryngotracheoesophageal cleft.